Biome Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
8

- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1.5M
- Investors
-
4
Biome General Information
Description
Operator of a clean-tech company intended to develop products that enhance indoor well-being. The company designs indoor bio-walls that are optimized to produce clean indoor air and provide data about the environment inside the rooms, hardware, software, and greenware into devices, focuses on atmospheric water generation to refill on-board water reservoirs, and IoT sensing to automate on-device settings, assists plant irrigation and maintenance with no plumbing or human intervention, enabling residents with easy access to nature, purified air, and environmental data monitoring.
Contact Information
Website
www.biome.usCorporate Office
- 315 Jefferson Street
- Oakland, CA 94607
- United States
Corporate Office
- 315 Jefferson Street
- Oakland, CA 94607
- United States
Biome Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Seed Round | 01-Jun-2022 | $1.5M | Completed | Generating Revenue | ||
2. Seed Round | 01-Jan-2018 | Completed | Startup | |||
1. Accelerator/Incubator | 01-Jun-2015 | $250K | $250K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Biome Patents
Biome Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4438051-A1 | Microbiome-based composition for preventing and treating multidrug resistant bacterial infections | Pending | 28-Mar-2023 | ||
US-20240325466-A1 | Microbiome-based composition for preventing and treating multidrug-resistant bacterial infections | Pending | 28-Mar-2023 | ||
EP-4039794-A1 | Staphylococcus epidermidis strain having immunity-enhancing activity and antibacterial activity against pathogenic bacteria, and use thereof | Pending | 02-Oct-2019 | ||
US-20220347229-A1 | Staphylococcus epidermidis strain having immunity-enhancing activity and antibacterial activity against pathogenic bacteria, and use thereof | Pending | 02-Oct-2019 | ||
EP-4039794-A4 | Staphylococcus epidermidis strain having immunity-enhancing activity and antibacterial activity against pathogenic bacteria, and use thereof | Pending | 02-Oct-2019 | C12N1/205 |
Biome Signals
Biome Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Bonaventure Capital | Venture Capital | Minority | ||
Cool Climate Collective | Angel Group | Minority | ||
Gaingels | Venture Capital | Minority | ||
Baiada Institute of Entrepreneurship | Accelerator/Incubator | Minority |
Biome FAQs
-
When was Biome founded?
Biome was founded in 2014.
-
Where is Biome headquartered?
Biome is headquartered in Oakland, CA.
-
What is the size of Biome?
Biome has 8 total employees.
-
What industry is Biome in?
Biome’s primary industry is Other Consumer Durables.
-
Is Biome a private or public company?
Biome is a Private company.
-
What is Biome’s current revenue?
The current revenue for Biome is
. -
How much funding has Biome raised over time?
Biome has raised $2.75M.
-
Who are Biome’s investors?
Bonaventure Capital, Cool Climate Collective, Gaingels, and Baiada Institute of Entrepreneurship have invested in Biome.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »